Consolidated Planning Corp’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$4.2M Sell
2024
Q3
$6.56M Buy
2024
Q2
$7.72M Buy
2024
Q1
$6.73M Sell
2023
Q4
$5.81M Buy
2023
Q3
$5.07M Buy
2023
Q2
$4.4M Buy
2023
Q1
$4.29M Sell
2022
Q4
$5.54M Buy
2022
Q3
$3.95M Sell
2022
Q2
$4.55M Buy